Superworth

Mirum Pharmaceuticals profit margin MIRM

Gross, operating and net profit as a share of revenue over the last twelve months, from 2022.

Net margin, 12 months
n/m
not a meaningful number
Peer median
18.1%

Mirum Pharmaceuticals' net margin works out at −139% over the last twelve months, but it is not a meaningful number: a margin outside minus 100% to 100% is moved by items that are not sales.

Profit margin over time

OperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating margin
FY2025−4.5%−4.2%
FY2024−26.1%−26.0%
FY2023−87.7%−58.6%
FY2022n/an/a
FY2021n/an/a
FY2020n/an/a
FY2019n/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26n/an/an/a
Q1 FY26n/an/an/a
Q4 FY25−4.5%+21.6 pts−4.2%
Q3 FY25−8.8%+23.7 pts−8.9%
Q2 FY25−13.6%+27.6 pts−13.3%
Q1 FY25−20.4%+50.4 pts−20.1%
Q4 FY24−26.1%+61.6 pts−26.0%
Q3 FY24−32.5%n/a−31.3%
Q2 FY24−41.3%n/a−41.0%
Q1 FY24−70.8%n/a−48.4%
Q4 FY23−87.7%n/a−58.6%
Q3 FY23n/an/a−76.5%

Against its peers

Companies in Drug Manufacturers - General nearest Mirum Pharmaceuticals' size, closest first, today.

CompanyProfit margin
MIRMMirum Pharmaceuticalsn/m
KNSAKiniksa Pharmaceuticals International9.6%
LGNDLigand Pharmaceuticals67.9%
AMRXAmneal Pharmaceuticals5.0%
INDVIndivior Pharmaceuticals26.7%
ARQTArcutis Biotherapeutics6.1%
LQDALiquidia30.7%
ALKSAlkermes plc.4.0%
OGNOrganon3.4%
TGTXTG Therapeutics55.2%
PTGXProtagonist Therapeutics29.4%
Peer median18.1%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Mirum Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.